ICU Medical, Inc. Announces the Appointment of Laurie Hernandez as its New Director of the Company, Effective July 1, 2021
July 07, 2021 at 04:14 pm EDT
Share
ICU Medical, Inc. announced that on July 1, 2021, the Board of Directors of the Company elected Ms. Laurie Hernandez as the new director of the Company, effective July 1, 2021. The Board determined that Ms. Hernandez will be an independent director within the meaning of the listing requirements of NASDAQ. Ms. Hernandez will stand for election by the Company's stockholders at the 2022 Annual Meeting of Stockholders, which is expected to be held in May 2022.
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.
ICU MEDICAL, INC. 
